Beijing Bohui Innovation Biotechnology Group Valuation

Is 300318 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 300318 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate 300318's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate 300318's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 300318?

Key metric: As 300318 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 300318. This is calculated by dividing 300318's market cap by their current revenue.
What is 300318's PS Ratio?
PS Ratio	5.4x
Sales	CN¥885.39m
Market Cap	CN¥4.75b

300318 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	7.5x
Enterprise Value/EBITDA	39.9x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does 300318's PS Ratio compare to its peers?

The above table shows the PS ratio for 300318 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	11.1x
688626 Xiangyu MedicalLtd	6.6x	25.3%	CN¥4.7b
688677 Qingdao NovelBeam TechnologyLtd	10.5x	29.1%	CN¥4.3b
688277 Tinavi Medical TechnologiesLtd	26.4x	n/a	CN¥4.5b
300358 Truking Technology	0.8x	10.9%	CN¥4.5b
300318 Beijing Bohui Innovation Biotechnology Group	5.4x	n/a	CN¥4.7b

Price-To-Sales vs Peers: 300318 is good value based on its Price-To-Sales Ratio (5.4x) compared to the peer average (11.1x).

Price to Sales Ratio vs Industry

How does 300318's PS Ratio compare vs other companies in the CN Medical Equipment Industry?

2 Companies	Price / Sales	Estimated Growth	Market Cap
002382 Blue Sail MedicalLtd	0.9x	n/a	US$745.21m
300358 Truking Technology	0.8x	10.9%	US$615.54m

No more companies available in this PS range

2 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Sales vs Industry: 300318 is good value based on its Price-To-Sales Ratio (5.4x) compared to the CN Medical Equipment industry average (6.3x).

Price to Sales Ratio vs Fair Ratio

What is 300318's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

300318 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	5.4x
Fair PS Ratio	n/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate 300318's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Shenzhen Lifotronic Technology

CN¥7.0b

Research, develops, manufactures, and markets medical devices for diagnostics, clinical medicine, skin, and human health related purposes in China.

688389

CN¥16.32

-6.6%

-29.4%

Truking Technology

CN¥4.5b

Engages in medical equipment business in China and internationally.

300358

CN¥7.54

-6.6%

-36.9%

Chison Medical Technologies

CN¥2.8b

Manufactures and sells diagnostic ultrasound systems in China and internationally.

688358

CN¥24.86

-7.0%

-45.4%